Every year, thousands of tons of brown algae are extracted from the seabed to obtain compounds such as alginates, a polymer ...

Array Bridge is testing promising drug candidates that can effectively bind and even degrade target proteins, but not via their active sites.

A new study published in Molecular Medicine Reports finds that nanoparticles made from Cannabis sativa stems could have ...

BMS-986458 features three stereocenters, one of which epimerizes easily, Mortensen said. The drug candidate, which would be ...

FAMU-FSU College of Engineering researchers have created a new method for studying protein degradation within immune cells ...

And because the enzyme was designed to precisely target ... the lab is now applying the methodology developed here to the degradation of key proteins involved in cancer, including c-Myc and ...

Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at Beijing Friendship Hospital, Capital Medical University, published a review ...

About NRX-0305 NRX-0305 is a potent, selective, and orally bioavailable mutant-specific BRAF degrader that Nurix is exploring for use in oncology. Nurix has reported preclinical data demonstrating ...

Tharimmune (THAR) announced preclinical results for its novel oral antibody, TH023. In a murine model, a proprietary protease enzyme stabilized ...

Tharimmune, Inc. (Nasdaq:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company focused on immunology and inflammation, today announced positive preclinical results for its ...

Digestive enzymes are found in the digestive system, including the mouth, stomach, and small intestine. They help you break down food and absorb nutrients. Sometimes, the body cannot make enough ...